FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study

Differentiating local recurrence from post-treatment changes on PET scans following stereotactic ablative radiotherapy (SABR) or hyperfractionation for lung tumors is challenging. We performed a prospective pilot study of 3-deoxy-3-[18F]-fluorothymidine (FLT)-PET-CT in patients with equivocal post-r...

Full description

Bibliographic Details
Main Authors: Susan M. Hiniker, Quaovi Sodji, Andrew Quon, Paulina M. Gutkin, Natasha Arksey, Edward E. Graves, Frederick T. Chin, Peter G. Maxim, Maximilian Diehn, Billy W. Loo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Oncology
Subjects:
stereotactic ablative radiotherapy
3-deoxy-3-[18F]-fluorothymidine
positron emission tomography
thoracic malignancy
disease recurrence
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00467/full

Similar Items

Similar Items